Navigation Links
SearchMedica's Second Quarterly 'Top Clinical Search Terms' Report Reveals Top 25 Oncology, General Medicine and Psychiatry Search Terms Among Medical Professionals
Date:2/13/2008

medicine.

For the full SearchMedica Clinical Search Terms Quarterly Report, email requests to ksmith@preturn.com.

SearchMedica.com recently was acknowledged for its outstanding user experience as a recipient of a 2007 Standard of Excellence WebAward.

About SearchMedica.com:

SearchMedica.com indexes only authoritative medical information, approved for inclusion by medical editors and a physician editorial board. Medical professionals receive more relevant, smaller sets of search results from SearchMedica.com than from mainstream engines, which contain consumer-oriented, paid testimonials and other types of unreliable information. Since SearchMedica.com is advertiser supported, medical professionals pay nothing to use the specialty search engine. All SearchMedica search results are independent and unbiased. They contain well-known, credible journals, peer-reviewed research, and evidence-based articles written for practicing healthcare professionals. SearchMedica is currently available at http://www.SearchMedica.com.

Media Contact:

Kraig Smith

PReturn Inc.

312.432.9405

ksmith@preturn.com


'/>"/>
SOURCE SearchMedica
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Transition Therapeutics Announces Second Quarter Fiscal 2008 Financial Results
2. Dynatronics to Release Second Quarter Results Thursday, February 14, 2008; Conference Call Set for 4:30 p.m. ET
3. Biotel Announces Strong Results for the Second Quarter Ended December 31, 2007
4. Nutrition 21 Reports Fiscal Second Quarter 2008 Financial Results
5. Rural/Metro Announces Results for Fiscal 2008 Second Quarter
6. Palatin Technologies, Inc. Reports Fiscal Year 2008 Second Quarter Results; Teleconference and Webcast to be held on February 11, 2008
7. Neurobiological Technologies Reports Second Quarter Financial Results
8. Two Little Hands Productions, Creators of Popular Childrens TV Series Signing Time, Debuts Second Season at This Years Toy Fair 2008
9. Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2008 Financial Results on Tuesday, February 12, 2008 at 5:00 P.M. EST
10. Bioniche Reports Fiscal 2008 Second Quarter
11. Hillenbrand Industries Announces Second Quarter 2008 Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)...NSA new three-drug combination has shown in a phas...ve regimen" in the treatment of patients newly dia...ood cells in bone marrow, say researchers from Dan...r better were seen in all of the 66 patients treat...tudy, with 74 percent having a "very good partial ...
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
Breaking Medicine News(10 mins):Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2
...ng is a statement of Matthew L. Myers, President, ...p://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOG...auds U.S. Senator Jeff Merkley (D-OR) for his lead...cts, including the authority to crack down on toba...
...ng is a Statement of Matthew L. Myers President, C...://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO...uds U.S. Senator Sherrod Brown (D-OH) for his lead...cts, including the authority to crack down on toba...
...ng is a statement of Matthew L. Myers, President, ...p://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOG...auds U.S. Senator Christopher Dodd (D-CT) for his ...roducts, including the authority to crack down on ...
...hore University HealthSystem Researcher reports in... Evanston, IL (Vocus) May 20, 2009 -- A... authored by David J. Winchester , FACS, M.D., Ch... nodes may not need a radical lymph node surgery. ...
...alance, Inc. (Nasdaq: SMBL ) today held its Annu... , Smart Balance Chairman and CEO Stephen Hughes ... and growth plans for the future. "Over the past ...es said. "We are excited as ever about the future...
...iation of Flight Attendants-CWA (AFA-CWA) today te...ose after a recent public health emergency and the...use of Representatives Subcommittee on Aviation co...elieve that we must be given the tools and ability...
Other Medicine News:Health News:Sen. Jeff Merkley Votes to Protect America's Kids From Tobacco 2Health News:Sen. Jeff Merkley Votes to Protect America's Kids From Tobacco 3Health News:Sen. Sherrod Brown Votes to Protect America's Kids from Tobacco 2Health News:Sen. Sherrod Brown Votes to Protect America's Kids from Tobacco 3Health News:Sen. Christopher Dodd Leads Fight to Protect America's Kids From Tobacco 2Health News:Sen. Christopher Dodd Leads Fight to Protect America's Kids From Tobacco 3Health News:Breast Cancer Patients May be Spared Additional Surgery 2Health News:Breast Cancer Patients May be Spared Additional Surgery 3Health News:Association of Flight Attendants-CWA Testifies on Emergency Planning After Recent Flu Outbreak 2
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
(Date:12/4/2009)STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 1Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 2Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 3ReBuilder Medical Technologies Inc Announces New York Marketing Agreement 55421 1ReBuilder Medical Technologies Inc Announces New York Marketing Agreement 55421 2PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 1PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 2PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 3
...d Acetaldehyde Levels in Subset of,Subjects with I..., Nov. 11 Raptor,Pharmaceuticals Corp. ("Raptor" ...y announced positive results in its Phase IIa stud...th ALDH2 deficiency, or ethanol,intolerance, as th...ogram.,Convivia(TM) is Raptor,s proprietary oral f...
...es patient screening for enrollment, SOUTH SAN FR...nc. (Nasdaq: RIGL ) today announced that the prev...ial of R788 (fostamatinib,disodium), the company,s...vember 2008 issue of Arthritis and Rheumatism. The...tis with a syk kinase inhibitor: A,twelve-week, ra...
Other Medicine Technology:Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 2Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 3Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 4Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 5Rigel's R788 Phase 2a Results Published in Arthritis and Rheumatism 2Rigel's R788 Phase 2a Results Published in Arthritis and Rheumatism 3
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: